• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[(11C)乙酸盐正电子发射断层扫描在前列腺癌中的应用。代谢成像的新前景]

[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].

作者信息

Hautzel H, Müller-Mattheis V, Herzog H, Roden W, Coenen H H, Ackermann R, Müller-Gärtner H W, Krause B J

机构信息

Nuklearmedizinische Klinik, Heinrich-Heine-Universität Düsseldorf.

出版信息

Urologe A. 2002 Nov;41(6):569-76. doi: 10.1007/s00120-002-0244-9.

DOI:10.1007/s00120-002-0244-9
PMID:12524944
Abstract

The exact staging of prostate cancer is mandatory to allow selection of the appropriate primary therapy. In addition, if the PSA level rises again it is extremely important to find the site(s) of local recurrence or metastatic spread as soon as possible. However, with the morphological and metabolic imaging techniques currently available it is often not possible to answer these questions with adequate sensitivity and specificity, since small metastases < or = 1 cm in diameter are likely to remain undetected by them. In the last few years new radioactive labelled tracers have been introduced for use in positron emission tomography (PET), and it is hoped that the shortcomings in the diagnostic procedures used for prostate carcinoma might be compensated by their use. Besides 11C- or 18F-labelled choline, [11C]Acetate is also attracting attention as a promising PET tracer. In this paper we review the various PET tracers available and evaluate the advantages and the drawbacks of [11C]Acetate in three case studies by comparing [11C]Acetate-PET with histology and with other imaging techniques. The use of [11C]Acetate appears to be feasible and helpful in the diagnosis of prostate carcinoma. However, its final value relative to other imaging techniques needs further investigation, with special reference to initial lymph node involvement, early localisation of recurrence and possible noninvasive differentiation between prostate cancer, prostatis and benign hyperplasia of the prostate.

摘要

前列腺癌的准确分期对于选择合适的初始治疗至关重要。此外,如果前列腺特异性抗原(PSA)水平再次升高,尽快找到局部复发或转移扩散的部位极其重要。然而,就目前可用的形态学和代谢成像技术而言,往往无法以足够的敏感性和特异性回答这些问题,因为直径小于或等于1厘米的小转移灶很可能无法被它们检测到。在过去几年中,已引入新的放射性标记示踪剂用于正电子发射断层扫描(PET),人们希望通过使用这些示踪剂来弥补前列腺癌诊断程序中的不足。除了11C或18F标记的胆碱外,[11C]醋酸盐作为一种有前景的PET示踪剂也备受关注。在本文中,我们回顾了各种可用的PET示踪剂,并通过将[11C]醋酸盐PET与组织学及其他成像技术进行比较,在三个病例研究中评估了[11C]醋酸盐的优缺点。[11C]醋酸盐的使用在前列腺癌诊断中似乎是可行且有帮助的。然而,相对于其他成像技术,其最终价值需要进一步研究,尤其要关注初始淋巴结受累情况、复发的早期定位以及前列腺癌、前列腺炎和前列腺良性增生之间可能的无创鉴别。

相似文献

1
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].[(11C)乙酸盐正电子发射断层扫描在前列腺癌中的应用。代谢成像的新前景]
Urologe A. 2002 Nov;41(6):569-76. doi: 10.1007/s00120-002-0244-9.
2
Positron emission tomography for prostate, bladder, and renal cancer.用于前列腺癌、膀胱癌和肾癌的正电子发射断层扫描。
Semin Nucl Med. 2004 Oct;34(4):274-92. doi: 10.1053/j.semnuclmed.2004.06.004.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.[11C]胆碱正电子发射断层扫描在前列腺癌再分期中的价值:与[18F]氟脱氧葡萄糖正电子发射断层扫描的比较。
J Urol. 2003 Apr;169(4):1337-40. doi: 10.1097/01.ju.0000056901.95996.43.
5
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.前列腺癌的11C-乙酸盐PET成像:在PSA复发时检测复发性疾病
J Nucl Med. 2003 Apr;44(4):549-55.
6
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.11C-胆碱正电子发射断层扫描在局限性前列腺癌治疗后的评估中的应用
Eur Urol. 2003 Jul;44(1):32-8; discussion 38-9. doi: 10.1016/s0302-2838(03)00207-0.
7
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.11C-乙酸盐和18F-FDG正电子发射断层扫描在前列腺癌患者中的应用。
Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):607-11. doi: 10.1007/s00259-002-1104-y. Epub 2003 Feb 13.
8
Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature.C-11-乙酸盐正电子发射断层扫描(PET)成像在前列腺癌中的应用:文献的系统评价和荟萃分析。
BJU Int. 2013 Dec;112(8):1062-72. doi: 10.1111/bju.12279. Epub 2013 Aug 13.
9
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.氟-18-氟脱氧葡萄糖正电子发射断层扫描在检测前列腺癌根治术后局部复发方面毫无用处。
Eur Urol. 1999;36(1):31-5. doi: 10.1159/000019923.
10
Positron-emission tomography in imaging and staging prostate cancer.正电子发射断层扫描在前列腺癌成像和分期中的应用
Cancer Biomark. 2008;4(4-5):277-84. doi: 10.3233/cbm-2008-44-509.

引用本文的文献

1
Performance characteristics and relationship of PSA value/kinetics on carbon-11 acetate PET/CT imaging in biochemical relapse of prostate cancer.前列腺癌生化复发时,碳-11 乙酸盐 PET/CT 成像中 PSA 值/动力学的性能特征及关系
Am J Nucl Med Mol Imaging. 2017 Jan 15;7(1):1-11. eCollection 2017.
2
Radiosynthesis and biological evaluation of N-[18F]labeled glutamic acid as a tumor metabolic imaging tracer.N-[¹⁸F]标记谷氨酸作为肿瘤代谢显像剂的放射性合成及生物学评价
PLoS One. 2014 Mar 28;9(3):e93262. doi: 10.1371/journal.pone.0093262. eCollection 2014.
3
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
[¹⁸F] - 胆碱PET/CT在前列腺癌分期及再分期中的应用评估
Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):253-63. doi: 10.1007/s00259-007-0552-9. Epub 2007 Oct 10.
4
[Innovative concepts in early cancer detection and staging of localized prostate cancer].[局限性前列腺癌早期检测与分期的创新理念]
Urologe A. 2005 Nov;44(11):1262, 1264-6, 1268-70, 1272-5. doi: 10.1007/s00120-005-0931-4.